Books > Medicine > Clinical & internal medicine > Haematology
|
Not currently available
New Findings on Aclarubicin in the Treatment of Acute Myeloid Leukemia (Paperback)
Loot Price: R2,371
Discovery Miles 23 710
|
|
New Findings on Aclarubicin in the Treatment of Acute Myeloid Leukemia (Paperback)
Supplier out of stock. If you add this item to your wish list we will let you know when it becomes available.
|
Since the introduction of new anthracycline derivatives and
anthrachi none analogues a few years ago, aclacinomycin A
(Aclarubicin) has become an established agent for the treatment of
hematologic malig nancies. A special symposium was therefore held
during the congress of the German Society of Hermatology and
Oncology in Hannover in October 1989 to provide an up-to-date
overv.iew. Leading experts from the United States, Sweden, and
Germany reported on the results being obtained with aclacinomycin
A, alone or combined with other agents, in patients with acute
leukemias and myelodysplastic syndromes. This book is based on
their contributions. As regards single-agent treatment,
aclacinomycin A in myelodys plastic syndromes is dealt with, as
well as its application in older patients with acute myeloid
leukemia. Four contributions are devoted to the use of
aclacinomycin A in combination with conventional or intermediate
dose cytosine arabinoside or etoposide in patients with relapsed or
refractory acute myeloid leukemia. The results reported indicate
that aclacinomycin A has substantial activity in the treatment of
hematologic malignancies. In summary, this book provides a valuable
update on the current status of aclacinomycin A as used by experts
in the treatment of he matologic malignancies."
General
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!
|
You might also like..
|
Email address subscribed successfully.
A activation email has been sent to you.
Please click the link in that email to activate your subscription.